Trials / Conditions / LN
LN
3 registered clinical trials studyying LN — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. NCT07203404 | Nanjing Bioheng Biotech Co., Ltd. | EARLY_Phase 1 |
| Terminated | Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) NCT05097989 | Alexion Pharmaceuticals, Inc. | Phase 2 |
| Terminated | Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 NCT02682407 | Omeros Corporation | Phase 2 |